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Chloroformate Derivatization for Tracing the Fate of Amino Acids 
in Cells and Tissues by Multiple Stable Isotope Resolved 
Metabolomics (mSIRM)
Ye Yanga,b, Teresa W-M. Fana,b, Andrew N. Lanea,b, and Richard M. Higashia,b
aCenter for Environmental and Systems Biochemistry, University of Kentucky, Lexington, KY, 
40539
bDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40539
Abstract
Amino acids have crucial roles in central metabolism, both anabolic and catabolic. To elucidate 
these roles, steady-state concentrations of amino acids alone are insufficient, as each amino acid 
participates in multiple pathways and functions in a complex network, which can also be 
compartmentalized. Stable Isotope-Resolved Metabolomics (SIRM) is an approach that uses atom-
resolved tracking of metabolites through biochemical transformations in cells, tissues, or whole 
organisms. Using different elemental stable isotopes to label multiple metabolite precursors makes 
it possible to resolve simultaneously the utilization of these precursors in a single experiment. 
Conversely, a single precursor labeled with two (or more) different elemental isotopes can trace 
the allocation of e.g. C and N atoms through the network.
Such dual-label experiments however challenge the resolution of conventional mass spectrometers, 
which must distinguish the neutron mass differences among different elemental isotopes. This 
requires ultrahigh resolution Fourier transform mass spectrometry (UHR-FTMS). When combined 
with direct infusion nano-electrospray ion source (nano-ESI), UHR-FTMS can provide rapid, 
global, and quantitative analysis of all possible mass isotopologues of metabolites. Unfortunately, 
very low mass polar metabolites such as amino acids can be difficult to analyze by current models 
of UHR-FTMS, plus the high salt content present in typical cell or tissue polar extracts may cause 
unacceptable ion suppression for sources such as nano-ESI.
Here we describe a modified method of ethyl chloroformate (ECF) derivatization of amino acids to 
enable rapid quantitative analysis of stable isotope labeled amino acids using nano-ESI UHR-
FTMS. This method showed excellent linearity with quantifiable limits in the low nanomolar 
range represented in microgram quantities of biological specimens, which results in extracts with 
total analyte abundances in the low to sub-femtomole range. We have applied this method to 
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profile amino acids and their labeling patterns in 13C and 2H doubly labeled PC9 cell extracts, 
cancerous and non-cancerous tissue extracts from a lung cancer patient and their protein 
hydrolysates as well as plasma extracts from mice fed with a liquid diet containing 13C6-glucose.
The multi-element isotopologue distributions provided key insights into amino acid metabolism 
and intracellular pools in human lung cancer tissues in high detail. The 13C labeling of Asp and 
Glu revealed de novo synthesis of these amino acids from 13C6-glucose via the Krebs cycle, 
specifically the elevated level of 13C3-labeled Asp and Glu in cancerous versus non-cancerous 
lung tissues was consistent with enhanced pyruvate carboxylation. In addition, tracking the fate of 
double tracers, (13C6-Glc + 2H2-Gly or 13C6-Glc + 2H3-Ser) in PC9 cells clearly resolved pools of 
Ser and Gly synthesized de novo from 13C6-Glc (13C3-Ser and 13C2-Gly) versus Ser and Gly 
derived from external sources (2H3-Ser, 2H2-Gly). Moreover the complex 2H labeling patterns of 
the latter were results of Ser and Gly exchange through active Ser-Gly one-carbon metabolic 
pathway in PC9 cells.
Graphical abstract
Keywords
Ultrahigh Resolution Fourier Transform Mass Spectrometry; Stable Isotope Resolved 
Metabolomics; Amino Acids; Direct infusion nano-electrospray
1. Introduction
1.1 Importance of amino acid metabolism
Amino acids play crucial roles in anabolic and catabolic metabolism. Not only are they the 
building blocks of proteins, they also are precursors to many key metabolites and oxidized to 
provide metabolic energy [1]. It was reported that amino acids account for the majority of 
dry cell mass in proliferating mammalian cells [2]. The non-essential amino acids Ala, Asp, 
and Glu play important roles in nitrogen metabolism via transamination, along with Arg, 
Orn, and citrulline in the urea cycle. Ser, Gly, Gln, and Asp are precursors in nucleotide 
synthesis, providing both carbon (Asp, Gly) and nitrogen (Gln, Asp) to the nucleobases [3]. 
Gln is also the nitrogen donor in the synthesis of amino sugars [4]. Arg, Orn, and Met are 
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also precursors of polyamines, which are essential in stress tolerance and nucleic acid 
function [5, 6]. These are just a few out of hundreds of vital metabolic roles of amino acids.
1.2 Stable Isotope-Resolved Metabolomics (SIRM) for robust pathway tracing
It is therefore crucially important to quantify amino acids to measure changes in 
concentrations and help determine their transformation pathways. The metabolic 
information contained in steady-state concentrations of metabolites, however, is often very 
limited, as each metabolite usually participates in multiple pathways, and most pathways are 
parallel, branched, reversible, and/or intersecting with each other to form a complex 
network. Thus, to robustly discern the precursor-product relationships for metabolic 
functions, it is necessary to “label” selected atoms in given metabolites so that their fates can 
be traced through metabolic pathways. Although radioisotopes such as 14C were popular 
tracers in the past [7–9], many studies now use stable isotopes since they are nonhazardous 
for ease-of-use, and key elements can be readily observed by both NMR (e.g. 13C and 15N) 
and MS, given sufficient sensitivity and resolution of the instruments [10, 11]. We have 
coupled stable isotope tracers with NMR and MS analysis in stable isotope-resolved 
metabolomics (SIRM) to track the provenance of individual atoms through various 
transformation pathways in cells, tissues and whole organisms (including human subjects) 
while still achieving wide metabolome coverage [10, 12–16]. By determining the label 
position (isotopomer) and number (isotopologue) distribution in the various metabolites, 
SIRM generates the information that is used to reconstruct the turnover in pathways and 
abundances of newly synthesized metabolites with low ambiguities, providing a solid 
foundation for metabolic flux determination [17–19].
1.3. Need for ultrahigh resolution Fourier transform mass spectrometry (UHR-FTMS)
Using multiple precursors, each with distinct stable isotopes, makes it possible to 
simultaneously discern intersecting, cyclical, and even compartmentalized pathways in a 
single experiment, thereby providing novel insights into metabolic networks as perturbed by 
disease or other stressors. For example, administering 13C6-glucose and 2H2-Gly 
simultaneously to a biological system would enable not only tracing of glycolysis, the Krebs 
cycle, pentose phosphate pathway (PPP), nucleotide synthesis, and one carbon metabolism 
pathway but also delineation of the fate of de novo synthesized or exogenously derived Gly. 
Interpretations would be initially based on well-established networks [20].
Stable isotopes such as 13C, 15N, and 2H differ from their most abundant isotopes by a single 
neutron. The apparent mass of a neutron in the nucleus differs slightly for each element due 
to differential nuclear binding energy [21]. The resulting mass difference for a molecule 
where 12C was substituted by 13C, versus 14N substituted by 15N, is too small to be resolved 
by the common “high resolution” mass spectrometers such as time-of-flight (TOF) MS with 
a maximum mass resolution (which is generally defined as m1/(m1-m2), where m1 and m2 
are two peaks of equal intensity with less than 10% overlap, and by convention stated for an 
m/z such as 400 [22]) up to about 60,000. Instead, they can be distinguished using 
sufficiently high m/z resolution, as afforded by certain models of Fourier transform mass 
spectrometers (FTMS) [10, 13]. In practice, we have found that UHR-FTMS with a minimal 
resolving power in excess of 200,000 (at 400 m/z, 10% valley) is required [13, 22], and 
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usually a resolving power of 400,000 or more is needed [22–25]. In addition to “ultra” high 
resolution, all current models of UHR-FTMS instruments are capable of high m/z accuracy 
(<0.2 ppm RMS error with external calibration) for operative assignment of molecular 
formula candidates, yet have high sensitivity permitting quantification of analytes at low 
femtomole abundance in a sample [10].
1.4 Considerations of analyte derivatization for chromatography versus direct infusion 
UHR-FTMS
Most, if not all, MS-based analytical methods reported for quantitative analysis of amino 
acids in biological systems have been in combination with gas-liquid chromatography (GC) 
or liquid chromatography (LC). N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide, 
introduced by Fan et al. in 1986 for GCMS analysis of organic and amino acids [26], has 
been a widely used silylation method for GC-based quantification of amino acids in 
biological materials. This method provides a high yield of molecular-ion isotopologue 
patterns under electron ionization [26–28], making it well suited for SIRM studies. 
Subsequently, Husek [29] reported a method of derivatizing amino acids with ethyl 
chloroformate (ECF) and demonstrated the fast analysis of amino acids by GCMS. Other 
researchers then modified the ECF derivatization method and applied it to a variety of 
materials including food, plant and urine samples [30, 31]. 9-Fluorenylmethyl-chloroformate 
(Fmoc-Cl) coupled with high performance liquid chromatography (HPLC) or fluorescence 
detection was also used to analyze amino acids in fruit juices and hydrolyzed peptides [32, 
33]. Related reagents such as isobutyl chloroformate, methyl chloroformate, 
pentafluorobenzyl chloroformate have also been reported in amino acids analysis using 
GCMS or LCMS [34–36], although none of these were intended for use with SIRM.
With chromatography sample introduction to the MS, the short duration of each analyte 
available to the MS limits signal averaging, often causing critical isotopologues to be 
undetected [25]. In addition, the rapidly changing concentrations presented to the MS from 
chromatography compromises the quality of isotopologue data required for accurate and 
reproducible quantification. In contrast, through extensive signal averaging, the continuous 
infusion UHR-FTMS acquisition can provide high quality spectra rapidly with expanded 
dynamic range and accurate molecular formulae. Among the direct infusion methods, we 
have chosen the nano-electrospray ionization source (nano-ESI) because of its high 
sensitivity and capability of small sample consumption (typically 15 μL) and negligible 
sample waste. The latter is crucial to the increasing demand for microanalysis of cell or 
tissue samples (particularly those from human subjects), which is a result of sample size 
limitations such as the need to share the same biospecimens with other analyses such as 
genomics, transcriptomics, and proteomics, plus a wide range of biological assessments 
needed for interpretation, i.e. immunohistochemistry. For these reasons, UHR-FTMS 
coupled with nano-ESI has been a high priority for SIRM studies.
1.5 Limitations of direct infusion FTMS analysis of amino acids can be overcome by 
derivatization
Nano-ESI-UHR-FTMS has been successfully applied to analyze lipids, nucleotides, and 
other metabolites in SIRM studies [10, 13, 23]. Despite this versatility, it has been difficult 
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to detect some low m/z and/or polar metabolites such as amino acids and polyamines in 
crude cell extracts because of the ion suppression and instability of any ESI ion source 
caused by the high salt content inherent in crude cell or tissue extracts. This increases 
sample consumption, compromises sample throughput due to re-analyses, and interferes 
with quantitative data analysis. Furthermore, all current UHR-FTMS models are optimized 
for analytes with m/z greater than 150, compromising performance for smaller m/z 
metabolites. These problems are exacerbated by the need to analyze numerous isotopologues 
present at very low abundance in SIRM experiments, even abundant metabolites whose 
monoisotopic species are readily detected by UHR-FTMS can have low enrichment 
isotopologues crucial for biochemical interpretation. Lastly, the biochemical liability of 
some metabolites makes them impractical to quantify with confidence. Therefore, there is a 
need to develop a suitable derivatization method for these small metabolites for nano-ESI-
UHR-FTMS analysis.
In this report, we have coupled ECF derivatization with nano-ESI-UHR-FTMS for 
microanalysis of amino acids. ECF can derivatize both –NH2 and –COOH groups on amino 
acids. After the ECF derivatization, all amino acids have an m/z greater than 170, which 
makes them suitable for UHR-FTMS analysis by current models. The derivatives are also 
more hydrophobic and can be extracted by chloroform to eliminate the salt effect. The 
derivatization can also stabilize some labile amino acids such as Gln. We applied the method 
to analyze the stable isotopologue distribution in polar extract of various isotope-labeled 
biological samples including single-opportunity surgical lung cancer patient tissues, lung 
cancer cells, patient-derived mouse xenograft tissues, hydrolyzed protein samples from these 
sources, and human plasmas.
2. Materials and Methods
2.1 Reagents
All unlabeled amino acid standards were purchased from Sigma Aldrich (St. Louis, MO) as 
a mixture of acidic and neutral amino acids (A6407) and basic amino acids (A6282). Gln, 
ethyl chloroformate (ECF), ethanol, pyridine and chloroform were also purchased from 
Sigma Aldrich. The uniformly 15N-labeled amino acids mixture was purchased from 
Cambridge Isotope Laboratories (NLM-6695, Cambridge, MA).
2.2 Methods
2.2.1 Preparation of amino acid standards—Immediately prior to analysis, the amino 
acids mixtures A6407 and A6282 were combined in equal volumes before experiments, and 
then a freshly prepared aqueous solution of Gln solution was added. In the final solution, the 
concentration of each amino acid was 0.556 mM except cystine, which was 0.278 mM. This 
stock was then serially diluted to concentrations of 0.278 mM, 0.111 mM, 0.056 mM, 0.028 
mM, 0.011 mM, 0.0056 mM and 0.0011 mM.
2.2.2 Preparation of unlabeled PC-9 cell polar extract—Human lung 
adenocarcinoma PC-9 cells were grown on 10 cm cell culture plates in Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) (Life Technologies, 
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Carlsbad, CA), 50 U mL−1 penicillin (Thermo Fisher Scientific), 50 μg mL−1 streptomycin 
(Fisher Scientific, Waltham, MA), 0.2% unlabeled glucose (MP Biomedicals, LLC) for two 
days. Then the media was changed to DMEM media containing 10% dialyzed FBS (Life 
Technologies, Carlsbad, CA), 50 U mL−1 penicillin, 50 μg mL−1 streptomycin, 2 mM Gln 
(Sigma Aldrich), 0.45% glucose, 0.4 mM unlabeled Ser (Sigma Aldrich) and 0.4 mM 
unlabeled Gly (Sigma Aldrich). After 24 h, the cells were quenched, harvested and extracted 
with CH3CN:H2O:CHCl3 (2:1.5:1) [37]. Then the aqueous phase containing polar extracts 
was distributed into aliquots and lyophilized for ECF derivatization.
2.2.3 Preparation of plasma polar extract from NOD/SCID/Gamma (NSG) mice 
fed with 13C6- Glc enriched liquid diet—The NOD/SCID/Gamma (NSG) mice were 
fed with a custom liquid diet in which 13C6-glucose is the primary carbohydrate source for 
18 h as described previously [38]. The mice were then sacrificed and 20 μl of plasma was 
extracted twice with 600 μL acetonitrile:methyl tert-butyl ether (MTBE):H2O (2:3:1) 
mixture to eliminate lipids [39]. Then the polar phase was deproteinized with 800 μL 
acetonitrile:acetone:methanol (8:1:1), followed by taking a 1/10 aliquot to lyophilize for 
ECF derivatization.
2.2.4 Preparation of lung cancer patient tissue polar extract—Both cancer tissues 
and surrounding non-cancer tissues of patients were collected in the operating room within 5 
minutes of resection from patient UK018 under our University of Kentucky Internal Review 
Board (IRB) protocol (IRB 14-0288-F6A). The tissues were cut into thin slices at 
approximately 0.7 to 1 mm thickness each. Paired cancer and non-cancer tissue slices were 
collected and incubated in glucose, Gly and Ser-free DMEM medium (Life Technologies, 
Carlsbad, CA) with 10% dialyzed fetal bovine serum, 50 U mL−1 penicillin, 50 μg mL−1 
streptomycin, 2 mM Gln, 0.4 mM Ser, 0.4 mM Gly and 0.45% 13C6-Glc (Sigma, St. Louis, 
MO). The slices were cultured at 37 °C with 5% CO2 for 24 h with gentle rocking as 
described [40]. The slices were quickly rinsed in cold PBS 3 times to remove any remaining 
media, vacuum aspirated, and then flash frozen in liquid N2. The frozen tissue slices were 
then homogenized in 60% cold CH3CN in a ball mill (Precellys-24, Bertin Technologies, 
Washington, DC, MD), then extracted with CH3CN:H2O:CHCl3 (2:1.5:1) [37]. Again the 
aqueous phase containing polar extracts was distributed into aliquots and lyophilized for 
ECF derivatization.
2.2.5 Hydrolysis of proteins from human lung tissues—After polar and lipid 
extraction of the ground tissue sample, the protein pellet was dried in a vacuum centrifuge 
and then extracted with 62.5 mM tris(hydroxymethyl)aminomethane (Tris) (Fisher 
Scientific) with 2% sodium dodecyl sulfate (SDS) (Fisher Scientific), 1 mM dithiothreitol 
(DTT) (Fisher Scientific), pH 6.8 [37]. The protein solution was precipitated with 10% 
trichloroacetic acid (TCA) (Fisher Scientific) and washed twice with H2O. Then the protein 
pellet was hydrolyzed in 6 N HCl with a focused beam microwave (CEM, Discover-SP, 
Matthews, NC, USA) at 160 °C for 10 min at a maximum power of 150 W, guided by 
previous work [41] and optimized by Y. Yang [42]. The hydrolyzed samples were then 
distributed into aliquots and lyophilized for ECF derivatization.
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2.2.6 Preparation of double tracer labeled PC-9 cell polar extract—Human lung 
adenocarcinoma PC-9 cells were grown on 10 cm cell culture plates in DMEM containing 
10% FBS, 50 U mL−1 penicillin, 50 μg mL-1 streptomycin, 0.2% unlabeled glucose for two 
days first. Then the media was changed to DMEM media containing 10% dialyzed fetal 
bovine serum, 50 U mL−1 penicillin, 50 μg mL−1 streptomycin and 2 mM Gln, and also with 
0.45% 13C6-Glc/0.4 mM unlabeled Ser/0.4 mM unlabeled Gly, or 0.45% 13C6-Glc/0.4 
mM 2H3-Ser (Cambridge Iosotope Laboratories, Tewksbury, MA)/0.4 mM unlabeled Gly, or 
0.45% 13C6-Glc/0.4 mM unlabeled Ser/0.4 mM 2H2-Gly (Cambridge Iosotope Laboratories, 
Tewksbury, MA) respectively for different isotope tracer groups. After 24 h, the cells were 
quenched, harvested and extracted with CH3CN:H2O:CHCl3 (2:1.5:1) [37]. Then the 
aqueous phase containing polar extracts was distributed into aliquots and lyophilized for 
ECF derivatization.
2.2.7 ECF derivatization—For the amino acid standards, 9 μL of each amino acid 
standard sample was used at the concentration stated in section 2.2.1. For the cell/tissue/
plasma polar extract, the freeze-dried fraction was used directly. H2O/Ethanol/Pyridine 
(6:3:1) mixture (100 μL) was added, followed by 5 μL of ECF. The mixture was allowed to 
react by vortexing for 30 s. Chloroform (100 μL) was then added to extract the products 
followed by 10 μL of 7 M NaOH to adjust the aqueous layer to pH 9–10, after which a 
further 5 μL of ECF was added and allowed to react again for 30 s. The solution was 
extracted a second time with 100 μL chloroform, and combined with the first extract. The 
combined chloroform extract was diluted 100 fold for the amino acid standards and 10 fold 
for cell or tissue samples with acetonitrile/water (9:1) solution to a final concentration of 20 
μM NaCl to convert the ions to their sodium adducts. The samples were then directly 
injected into the FTMS using nano-ESI for UHR-FTMS analysis.
2.2.8 Mass spectrometry and peak assignments—UHR-FTMS analysis was carried 
out using the Tribrid Fusion Orbitrap (Thermo Scientific, San Jose, CA, USA), interfaced 
with an Advion Triversa Nanomate (Advion Biosciences, Ithaca, NY, USA). The Nanomate 
was operated at 1.5 kV and 0.5 psi head pressure in positive ion mode. The maximum ion 
time for the automatic gain control (AGC) was set to 100 ms, acquiring 5 micro scans, and 
each sample was acquired for >5 min with m/z range 100–1000 selected using quadrupole 
isolation. For data analysis, a single spectrum was obtained for each sample by averaging 
spectra over the entire acquisition time.
All 12C, 13C, 15N and 2H isotopologue peaks were assigned using “PREMISE” 
(PRecalculated Exact Mass Isotopologue Search Engine) [13] based on their accurate m/z 
values and the natural abundance distribution of each isotopologue was corrected (or 
“stripped”) using the method developed by Moseley [43].
3. Results and discussion
3.1 Analysis of amino acid standards
The ECF derivatization method was first evaluated using the amino acid mixture (Figure A.1 
and Table 1). NMR analysis established that the ECF reaction efficiency was between 82–
99.9% for the amino acid standards (Table A.1), based on 15N labeled amino acids added as 
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internal standards for quantification. Since these 15N standards were added before reaction 
with ECF, the ratio between each amino acid and its spiked 15N counterpart was used to 
correct for the reaction and extraction efficiency, thus enabling quantification of each amino 
acid and its 13C labeled isotopologues despite lacking the actual reaction efficiency. Note 
that the use of UHR-FTMS enables the deployment of such isotopic surrogates as internal 
standards for biologically stable isotope labeled analytes. The ECF-derivatized amino acids 
were observed as sodium adducts except Arg, which was measured as the protonated form 
that dominated over the sodium adduct. For His and Lys, both protonated and Na adducts 
were present, but the Na adducts dominated at low concentrations.
For all amino acids tested, the UHR-FTMS quantification showed excellent linear response 
over more than three orders of magnitude with high sensitivity (Figure A.1 and Table 1), 
indicating that reliable absolute quantification of amino acids was achieved by this method. 
Leu and Ile are shown as a single entry as they are isobaric, and therefore are not resolved by 
direct infusion MS.
3.2 Analysis of amino acids in unlabeled polar extracts of PC9 cells
Direct analysis of cell extracts without derivatization by direct infusion nano-ESI UHR-
FTMS was unsuccessful, even after 100-fold dilution to reduce the ion suppression. 
However, after ECF derivatization and chloroform extraction, the nano-ESI spray was stable 
for more than fifteen minutes, which readily enabled sensitive detection and reliable 
quantification of amino acids and their isotopologues. Figure 1 shows a typical positive-ion 
mode spectrum of a polar extract of PC9 cells after ECF derivatization and chloroform 
extraction. Small amino acids such as Gly and Ala were now detected with good sensitivity 
(at low femtomole levels), even though their underivatized forms were difficult to analyze by 
direct infusion-FTMS due to their low m/z values.
3.3 Analysis of amino acids in plasma from NOD/SCID/Gamma (NSG) mice fed with 13C6-
Glc enriched liquid diet
Figure 2 summarizes the 13C enrichment of amino acids in mouse plasma after 18 h of 
feeding with 13C6-glucose diet. We found that about a third of the Ala was 13C3 labeled, and 
about half of Glu was 13C labeled (sum of all 13C isotopologues), indicating that about one 
third of Ala and one half of Glu in plasma was synthesized de novo from dietary glucose. 
The rationale is as follows: 13C3-Ala is synthesized from 13C6-Glc via the production 
of 13C3-pyruvate through glycolysis followed by transamination. 13C3-pyruvate can also 
enter the Krebs Cycle to produce 13C2-α-ketoglutarate, which can in turn generate 13C2-Glu 
via the action either of glutamate dehydrogenase or glutamate-α-ketoglutarate 
aminotransferase. The 13C2-Glu may subsequently be converted to 13C2-Gln by glutamine 
synthetase. Additional cycling through the Krebs cycle can produce 13C3-, 13C4 -, 13C1 - 
and 13C5-α-ketoglutarate and thus generate 13C3-, 13C4 13C1 - and 13C5-Gln via 
correspondingly labeled Glu. Glu, however, was present at low concentrations and showed 
very little 13C enrichment (Figure 2), which suggests the majority of Glu originated from the 
diet rather than by de novo synthesis from glucose, and further, the majority of newly 
synthesized Glu was consumed for Gln synthesis. The total concentrations of amino acids 
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measured (the sum of all isotopologues) in mice plasma was comparable to values reported 
in the literature [44].
3.4. Analysis of free amino acids in 13C6-Glc labeled tissue slices from a lung cancer 
patient
We obtained freshly resected cancerous (CA) and paired non-cancerous (NC) lung tissues 
from human subjects, which were thinly sliced and incubated in 13C6-Glc containing 
DMEM media, as previously described [25, 40]. Figure 3 shows the isotopologues of 
selected amino acids determined in these tissue slices. The left three figures show the 
absolute quantification of amino acids in NC versus CA tissue extracts normalized to protein 
weight (nmole/mg protein) while the right three figures show the corresponding fractional 
enrichment. We found that after 24 h of incubation with 13C6-Glc, about 14% Ala was 
synthesized de novo in NC tissues and 62% in CA tissues, which suggested higher 
glycolytic and aminotransferase capacity in CA tissues. This is consistent with the metabolic 
reprogramming shown previously [12]. In addition, 13C2-Asp and 13C3-Asp were 
synthesized, evidently via the pyruvate dehydrogenase (PDH) and pyruvate decarboxylase 
(PCB) reactions, respectively (Figure 4). The fractional enrichment data suggested that 
compared with paired NC tissue slices, CA tissue slices had a relatively higher capacity for 
PCB- than PDH-initiated Krebs cycle reactions, which was consistent with previous report 
[11]. Moreover, since 13C3- and 13C4-Glu can be produced from additional Krebs Cycle 
turns and 13C4-Glu can be synthesized from the PCB activity (Figure 4), the relatively 
higher enrichment of these isotopologues in the CA versus NC tissue slices pointed to more 
active Krebs cycle in the CA tissues. This is consistent with a higher energy and carbon 
demand of cancer cells to support their survival and growth.
3.5 Analysis of proteinaceous amino acids from lung cancer patient UK018
We also extracted protein fractions from the tissue slices of the same patient described 
above. To determine the incorporation of 13C labeled amino acids into proteins, we first 
hydrolyzed the protein extracts by microwave digestion using a modified method [41, 42] 
Independent of the hydrolysis efficiency, the fractional enrichment data of the isotopologues 
of each amino acid is reliable. Figure 5 shows the 13C fractional enrichment in amino acids 
hydrolyzed from the protein fraction of the lung cancer patient (UK018) tissue slice 
experiment. While the essential amino acids were unlabeled in the protein pool as expected, 
we observed appreciable 13C enrichment in non-essential amino acids, Glu, Ala, and Asp. 
The Glu and Asp data showed that the 13C enrichment was significantly increased in 
proteins from the CA tissue slices compared to the NC counterparts. It should be noted that 
Glu represented Glu+Gln as acid hydrolysis converts Gln to Glu. This result indicates that 
amino acids synthesized de novo from glucose were incorporated into proteins, and that the 
capacity of protein synthesis was higher in CA than in NC tissues. True protein turnover 
would require measurements of synthesis and degradation rates, which can be obtained with 
the present method but is beyond the scope of this report.
3.6. Analysis of amino acids in polar extracts of PC9 cells grown on dual labeled sources
Stable isotope labeling is indispensible for robust mapping of metabolic pathways. Due to 
the complexity of metabolic networks, even the single tracer approach is often insufficient in 
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terms of biochemical resolving power and coverage for gaining a comprehensive 
understanding of the system. The use of UHR-FTMS enables freedom to design experiments 
that multiplex different isotopes in the same experiment, including 13C, 15N and 2H (cf. 
Figure A2). We have grown PC9 cells in DMEM media for 24 h with 13C6-Glc + 2H2-Gly, 
or with 13C6-Glc + 2H3-Ser (see Methods) to distinguish the de novo synthesis of Ser and 
Gly (derived from 13C6-Glc) from metabolism of exogenous 2H labeled Ser or Gly present 
in the growth medium. Ser can be synthesized from glucose via the glycolytic intermediate 
3-phosphoglycerate (3-PGA) and Ser can be subsequently converted to Gly by the action of 
serine hydroxymethyl transferase (SHMT), as shown in Figure 6. This Ser-Gly-one carbon 
pathway provides precursors for the synthesis of purines [3]. Thus the enrichment of Ser and 
Gly with 13C is expected to proceed via this pathway. Both Ser and Gly, however, can be 
taken up from the medium, which can be simultaneously tracked using 2H-labeled Ser or 
Gly in the medium. The SHMT-catalyzed exchange between Ser and Gly may lead to 
scrambling of the deuterium label, which is discerned by ECF derivatization UHR-FTMS 
analysis independently of the 13C enrichment in the amino acids pools. Recent report has 
shown that Ser is more likely than Gly to support one-carbon metabolism and proliferation 
of cancer cells [45]. It is therefore crucial to understand the pools and fates of Ser and Gly in 
regard of cancer metabolism.
Figure 7 shows the Gly and Ser regions in the UHR-FTMS spectrum of a polar extract of 
dually labeled PC9 cells. The expanded region illustrates clear resolution of 13C2 - 
from 2H2-isotopologues of Gly, and 13C3- from 2H3-isotopologues of Ser, and Figure 8 
shows the fractional enrichment results of these assigned isotopologue species. After 24 h of 
growth in labeled cell media, about 20 to 30% of Gly and Ser were labeled with 13C only, 
which indicates de novo synthesis of Gly and Ser from glucose via glycolysis and the 3-PG 
pathway (Figure 6). A further 20–30% were 2H labeled only, indicating that these amino 
acids were newly imported from the external medium. However, more than half of the 
exogenously derived 2H3-Ser was converted to 2H2- and 2H1-Ser, while the main deuterated 
isotopologue of Gly was 2H1-Gly when either 2H3-Ser or 2H2-Gly was present in the 
medium. As before, these scrambled products of Ser and Gly indicated extensive deuterium 
exchange processes between Ser and Gly via 1-carbon metabolism, as catalyzed by SHMT, 
glycine decarboxylase complex (GLDC), and methylenetetrahydrofolate dehydrogenase 
(MTHFD).
4. Conclusions
We have harnessed and modified the rapid ECF derivatization coupled with nano-ESI-UHR-
FTMS method for microanalysis of amino acids. The resulting hydrophobic derivatives 
allowed use of chloroform extraction to minimize salt in polar extracts of biological 
samples, which avoided major matrix interferences. Together with the use of internal 15N 
labeled amino acid standards, we achieved highly sensitive, rapid, and reliable quantification 
of amino acids without the need for chromatography. Isobaric compounds such as Leu and 
Ile are not resolved with this new method, which would require chromatographic separation. 
We have applied this method to analyze amino acids in a wide range of biological matrices 
including cells, tissues, biofluids, and their protein hydrolysates. This, in turn, demonstrated 
the ability of mass spectrometry at sub-atomic (neutron) resolution to resolve dual tracers 
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(13C and 2H) simultaneously present in amino acids, thereby opening new avenues for 
studies of metabolic networks at the atom-resolved level.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported in part by National Institute of Health [5R01ES022191-04, 3R01ES022191-04S1, 
1U24DK097215-01A1 and P01 CA163223-01A1]. We thank Dr. Ronald Bruntz for the PC9 cell extraction, Ms. 
Yan Zhang for the UK022 tissue slice extraction, Dr. Ramon Sun for mouse sample preparation, and Dr. Penghui 
Lin for recording NMR spectra on the samples and for data reduction. We also thank Dr. Hunter Moseley for 
discussion of the natural abundance stripping.
Abbreviations
DMEM Dulbecco’s modified Eagle’s medium
ECF ethyl chloroformate
EI electron ionization
PPP pentose phosphate pathway
GC gas chromatography
LC liquid chromatography
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Highlights
• Chloroformate-based UHR-FTMS method shows excellent linear response to 
amino acids.
• UHR-FTMS resolves simultaneous 13C and 2H isotopologues of amino acids 
in mSIRM.
• Method was used to characterize metabolic change in lung cancer cells and 
tissues.
• Characterized metabolic changes in cancer are consistent with previous 
reports.
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Figure 1. Typical positive ion mode spectrum of an unlabeled polar extract of PC9 cells after 
derivatization with ECF
Panel A shows the full m/z range profile spectrum, which included the Na adducts of GSH 
and GSSG derivatives along with amino acid derivatives. Panel B shows the zoom-in profile 
spectrum in the amino acid range. The m/z peaks were assigned using “PREMISE” [13]. 
Most of the amino acids shown represented Na adduct species except for Arg and His, which 
were protonated species.
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Figure 2. 13C labeled amino acids in blood plasma of mice fed with a 13C6-glucose diet
Blood plasma from mice fed with the 13C6-glucose diet was obtained and treated as 
described in the methods. Isotopologues of the amino acids were determined via the ECF 
derivatives by UHR-FTMS. High 13C enrichment was observed in Ala (ca. 33%) and Gln 
(ca. 50%) but not in Glu (<10–15%).
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Figure 3. 13C labeling in human lung tissues
The polar extract of lung tissues slices incubated for 24 h in the presence of 13C6-glucose 
were processed as described in the methods. The amounts of different isotopologues of three 
amino acids were normalized to the tissue protein weight (left) and the fractional 
enrichments were calculated (right). Non-cancerous (NC, blue) and cancerous (CA, red) 
tissue slices procured from a lung cancer patient (UK018). N=2; error bars represent 
standard error of mean (SEM).
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Figure 4. 13C atom-resolved tracing of 13C6-Glc oxidation through the interconnecting 
cytoplasmic glycolysis and mitochondrial Krebs cycle
Panel A shows 13C incorporation from 13C6-Glc into various metabolites via the PDH 
(pyruvate dehydrogenase) pathway; panel B shows 13C incorporation from 13C6-Glc into 
metabolites via the PCB (pyruvate carboxylase) pathway. ●: 12C; ●: 13C; ●,● 
indicates 13C derived from PDH or PCB mediated Krebs cycle reactions, respectively; In 
panel A, the labeled patterns of the first and second (in brackets) turns of the PDH-initiated 
Krebs cycle are shown. In panel B, 13C3-pyruvate (Pyr) is carboxylated to form 13C3-
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oxaloacetate (OAA), leading to the formation of 13C3-Asp, -malate, -fumarate, and -
succinate (patterns outside brackets); the labeled structures in brackets are derived from the 
reaction of 13C3-OAA with 13C2- or unlabeled acetyl CoA (AcCoA) to form other labeled 
Krebs cycle intermediates after one cycle turn. α-KG: α-ketoglutarate; not all expected 
labeled patterns of metabolites are shown [10].
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Figure 5. Fractional enrichment of isotopologues in different amino acids hydrolyzed from non-
cancerous or cancerous tissue proteins
N=2; error bars represent SEM.
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Figure 6. De novo synthesis of Ser and Gly from glucose via glycolysis and the 3-
phosphoglycerate (3-PG) pathway and exchanges of exogenously derived Ser and Gly via one-
carbon metabolism
Selected Ser and Gly exchange reactions are depicted for the cytoplasmic and mitochondrial 
compartments to illustrate the production of different 2H isotopologues of Gly and Ser in 
Figs. 7 and 8. For example, the serine hydroxymethyl transferase (SHMT) reaction was 
shown for the cytoplasm (SHMT1) but omitted for the mitochondria (SHMT2) [10, 46]. 
Blue text blocks depict the de novo synthesis carbon pathway from 13C6-glucose while 
green and beige text blocks respectively depict the hydrogen exchange pathway of Gly and 
Ser via 1-carbon metabolism catalyzed by SHMT1, glycine decarboxylase complex 
(GLDC), and methylenetetrahydrofolate dehydrogenase (MTHFD). PHGDH: 
phosphoglycerate dehydrogenase; PSAT1: phosphoserine amino transferase 1; MTHFD2: 
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mitochondrial NAD+-dependent methylene tetrahydrofolate dehydrogenase/methylene 
tetrahydrofolate cyclohydrolase; MTHFD2L: mitochondrial NADP+-dependent methylene 
tetrahydrofolate dehydrogenase.
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Figure 7. UHR-FTMS of an extract of PC9 cells
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Panel A shows the UHR-FTMS profile spectrum of the Gly-ECF region of a polar extract of 
PC9 cells grown in a medium containing 13C6-Glc+2H2-Gly. Panel B shows the UHR-FTMS 
profile spectrum of the Ser-ECF region of a polar extract of 13C6-Glc+2H3-Ser labeled PC9 
cells.
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Figure 8. 
13C and 2H Isotopologue distribution of Ser and Gly in dually labeled PC9 cell extracts 
indicates extensive exchanges between the two amino acids. N=3; error bars represent SEM.
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Table 1
Linearity of response of the ECF-derivatized amino acids standard
Amino acids N Linearrange (nM) R
2
Ala 4 5-5000 0.995
Arg 4 5-5000 0.999
Asn 4 5-5000 0.997
Asp 4 5-5000 0.998
Cystine 4 5-1250 0.988
Glu 4 5-5000 0.990
Gln 4 5-5000 0.997
Gly 4 5-5000 0.994
His 4 5-5000 0.999
Leu+Ile 4 5-5000 0.999
Lys 4 5-5000 0.999
Met 4 5-5000 0.999
Phe 4 5-5000 1.000
Pro 4 5-5000 0.999
Ser 4 5-5000 0.992
Thr 4 5-5000 0.987
Trp 4 5-5000 0.998
Tyr 4 5-5000 1.000
Val 4 5-5000 0.997
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